Edition:
United Kingdom

Flex Pharma Inc (FLKS.OQ)

FLKS.OQ on NASDAQ Stock Exchange Global Market

3.49USD
5:29pm GMT
Change (% chg)

$-0.06 (-1.69%)
Prev Close
$3.55
Open
$3.53
Day's High
$3.59
Day's Low
$3.49
Volume
7,342
Avg. Vol
9,064
52-wk High
$6.28
52-wk Low
$2.68

Latest Key Developments (Source: Significant Developments)

Flex Pharma Q3 loss per share $0.54
Monday, 6 Nov 2017 

Nov 6 (Reuters) - Flex Pharma Inc ::Flex Pharma reports third quarter 2017 financial results.Q3 loss per share $0.54.Q3 revenue $414,000 versus I/B/E/S view $477,000.Q3 earnings per share view $-0.61 -- Thomson Reuters I/B/E/S.Flex Pharma Inc - ‍expects to have sufficient capital to fund operations into early 2019​.  Full Article

Flex Pharma reports positive topline data from exploratory phase 2 trial of FLX-787 in ALS
Monday, 6 Nov 2017 

Nov 6 (Reuters) - Flex Pharma Inc :Flex Pharma reports positive topline data from exploratory phase 2 trial of FLX-787 in ALS.Flex Pharma - ‍data from exploratory phase 2 trial of FLX-787 showed statistically significant reduction in cramp-associated pain intensity & stiffness​.Flex Pharma Inc - ‍FLX-787 was generally well tolerated​.  Full Article

Flex Pharma initiates CMT phase 2 trial with FLX-787 in US
Monday, 16 Oct 2017 

Oct 16 (Reuters) - Flex Pharma Inc :Flex Pharma initiates CMT phase 2 trial with FLX-787 in US.Flex Pharma Inc - ‍ALS phase 2 trial currently underway​.Flex Pharma Inc - ‍expects to report topline results from this study in middle of 2018​.  Full Article

Flex Pharma •Q2 loss per share $0.71
Wednesday, 3 Aug 2016 

Flex Pharma Inc : Q2 revenue $112,700 . Q2 revenue view $2,000 -- Thomson Reuters I/B/E/S . Flex pharma reports second quarter 2016 financial results . Q2 loss per share $0.71 .Q2 earnings per share view $-0.69 -- Thomson Reuters I/B/E/S.  Full Article

Flex Pharma CEO reports open market purchase of 33,400 shares of co's common stock - SEC filing
Thursday, 19 May 2016 

Flex Pharma Inc : CEO Christoph Westphal reports open market purchase of 33,400 shares of co's common stock on May 17 & 18 - SEC filing .CEO Westphal bought 18,200 shares on may 17 at average price of $11.14 each, and 15,200 shares on may 18 at average price of $11.05 each.  Full Article

BRIEF-Flex Pharma Inc - ‍Completed Enrollment In Its Phase 2 Exploratory Spasticity Study In Multiple Sclerosis With Approximately 50 Patients In Australia​

* FLEX PHARMA INC - ‍COMPLETED ENROLLMENT IN ITS PHASE 2 EXPLORATORY SPASTICITY STUDY IN MULTIPLE SCLEROSIS WITH APPROXIMATELY 50 PATIENTS IN AUSTRALIA​ Source text for Eikon: Further company coverage: